DERM
HEALTHCAREJourney Medical Corp
AI Insight
What's Moving DERM Today?
No stock-specific AI insight has been generated for DERM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.31$9.55
$6.88
Fundamentals
Market Cap$182M
P/E Ratio—
EPS$-0.37
Dividend Yield—
Dividend / Share—
ROE-36.6%
Profit Margin-14.8%
Debt / Equity—
Trading
Volume19K
Avg Volume (10D)—
Shares Outstanding21.5M
DERM News
21 articles- How The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation TargetYahoo Finance·Jun 3, 2026
- Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare ConferenceYahoo Finance·May 19, 2026
- Journey Medical Corporation Q1 2026 Earnings Call SummaryMoby·May 15, 2026
- Journey Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...Yahoo Finance·May 14, 2026
- Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 EarningsYahoo Finance·May 13, 2026
- Journey Medical (DERM) Q1 2026 Earnings TranscriptMotley Fool·May 13, 2026
- Transcript: Journey Medical Q1 2026 Earnings Conference CallYahoo Finance·May 13, 2026
- Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 13, 2026
- Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate HighlightsYahoo Finance·May 13, 2026
- Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top EstimatesYahoo Finance·May 7, 2026
- Zevra Therapeutics (ZVRA) Q1 Earnings and Revenues Surpass EstimatesYahoo Finance·May 6, 2026
- Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026Yahoo Finance·May 6, 2026
- Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should KnowYahoo Finance·May 6, 2026
- Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last?Yahoo Finance·May 5, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERMGlobeNewswire Inc.·Apr 28, 2026
- Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™Yahoo Finance·Apr 21, 2026
- Why The Journey Medical (DERM) Narrative Is Shifting With New Targets And Going Concern RisksYahoo Finance·Mar 30, 2026
- Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesYahoo Finance·Mar 26, 2026
- Journey Medical Corporation Q4 2025 Earnings Call SummaryMoby·Mar 26, 2026
- Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Mar 26, 2026
- Journey Medical Q4 Earnings Call HighlightsMarketbeat·Mar 26, 2026
All 21 articles loaded
Price Data
Open$6.79
Previous Close$6.70
Day High$7.18
Day Low$6.77
52 Week High$9.55
52 Week Low$4.31
52-Week Range
$4.31$9.55
$6.88
Fundamentals
Market Cap$182M
P/E Ratio—
EPS$-0.37
Dividend Yield—
Dividend / Share—
ROE-36.6%
Profit Margin-14.8%
Debt / Equity—
Trading
Volume19K
Avg Volume (10D)—
Shares Outstanding21.5M
About Journey Medical Corp
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—